new
highli
contagi
respiratori
diseas
caus
global
spread
high
case
fatal
rate
sever
patient
huge
medic
burden
due
invas
mechan
ventil
current
diagnosi
treatment
guidelin
still
need
improv
excel
clinic
experi
need
provid
refer
analyz
summar
clinic
data
confirm
adult
patient
includ
sever
case
includ
laboratori
examin
result
imag
find
treatment
effect
prognosi
etc
order
put
forward
predict
index
sever
patient
principl
earli
intervent
methylprednisolon
usag
patient
hypoxemia
hyperlact
acid
hypoproteinemia
hypokalemia
preval
patientsth
signific
low
lymphocyt
count
hypoproteinemia
hypokalemia
persist
worsen
high
crp
high
ddimer
high
bnp
occurr
hemoptysi
novel
coronaviru
viremia
import
indic
earli
diagnosi
predict
sever
diseas
progress
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
characterist
imag
lung
ct
clear
chang
covid
groundglass
opac
ggo
highdens
linear
combin
may
indic
differ
patholog
chang
rapid
lobular
progress
ggo
suggest
possibl
sever
diseas
basic
principl
earli
intervent
treatment
premis
effect
antivir
drug
treatment
base
support
symptomat
therapi
albumin
supplement
supplement
potassium
supplement
blood
plasma
etc
order
maintain
stabil
intracellular
environ
adequ
reactiv
bodi
immun
clean
accord
sever
oxygen
index
bodi
weight
age
underli
diseas
appropri
amount
methylprednisolon
applic
severecrit
patient
demand
improv
blood
oxygen
reduc
util
rate
invas
mechan
ventil
case
fatal
rate
medic
burden
significantli
common
indic
invas
mechan
ventil
strictli
control
critic
patient
time
identif
clinic
featur
sever
risk
earli
appropri
intervent
block
diseas
progress
dose
methylprednisolon
effect
avoid
invas
mechan
ventil
reduc
case
fatal
rate
critic
patient
new
highli
contagi
respiratori
diseas
caus
sever
acut
respiratori
syndrom
coronaviru
sudden
rapid
progress
acut
respiratori
distress
syndrom
ard
sever
fatal
featur
current
outbreak
caus
global
pandem
march
confirm
patient
death
provinc
china
world
confirm
case
confirm
death
high
case
fatal
rate
sever
patient
huge
medic
burden
caus
invas
mechan
ventil
nation
health
commiss
peopl
republ
china
issu
relev
diagnosi
treatment
guidelin
covid
updat
edit
also
refer
chines
covid
guidelin
diagnosi
treatment
propos
intern
orient
advic
diagnosi
treatment
howev
continu
recognit
new
diseas
believ
current
diagnosi
treatment
guidelin
still
need
improv
characterist
clinic
symptom
meaning
laboratori
examin
indic
diagnosi
basi
pneumonia
limit
glucocorticoid
usag
dosag
treatment
choic
mechan
ventil
time
excel
experi
clinic
diagnosi
treatment
need
refer
fifth
affili
hospit
sun
yatsen
univers
design
hospit
zhuhai
citi
admit
case
patient
success
cure
discharg
analysi
summari
diagnosi
treatment
process
patient
hope
provid
refer
advic
diagnosi
treatment
especi
accur
identifi
risk
sever
diseas
earli
block
diseas
progress
ration
appli
glucocorticoid
reduc
rate
invas
mechan
ventil
case
fatal
rate
sever
patient
studi
retrospect
singlecent
studi
includ
confirm
adult
patient
year
old
admit
fifth
affili
hospit
sun
yatsen
univers
januari
march
retrospect
observ
studi
approv
research
ethic
committe
fifth
affili
hospit
sun
yatsen
univers
need
inform
consent
waiv
consid
retrospect
studi
design
clinic
data
extract
electron
medic
record
includ
basic
demograph
data
symptom
vital
sign
clinic
classif
complic
rna
nasopharyng
swab
blood
sampl
clearanc
time
defin
time
two
consecut
neg
realtim
pcr
result
interv
diagnos
clinic
classifi
accord
new
coronaviru
pneumonia
diagnosi
treatment
plan
trial
version
categor
variabl
describ
frequenc
rate
percentag
continu
variabl
describ
use
mean
standard
deviat
median
interquartilerang
iqr
valu
mean
continu
variabl
compar
use
independ
group
test
one
way
anvoa
data
normal
distribut
homoscedast
otherwis
mannwhitney
u
test
kruskalw
h
use
data
nonnorm
distribut
proport
categor
variabl
compar
use
chisquar
test
although
fisher
exact
test
use
data
limit
statist
analysi
perform
use
spss
softwar
version
ibm
unadjust
comparison
twosid
p
consid
statist
signific
total
patient
posit
nasopharyng
swab
test
zhuhai
younger
year
old
belong
pediatr
diagnosi
treatment
first
case
death
case
among
adult
treat
medic
team
total
patient
treat
diagnosi
treatment
team
includ
analysi
report
sever
account
among
case
zhuhai
patient
local
resid
wuhan
live
wuhan
within
day
onset
case
hubei
area
outsid
wuhan
histori
direct
contact
personnel
hubei
anoth
case
clear
epidemiolog
histori
proport
sever
case
patient
directli
wuhan
lower
nonsever
case
proport
sever
case
patient
clear
epidemiolog
histori
higher
coincid
possibl
multipl
origin
new
coronaviru
clinic
symptom
found
patient
fever
short
breath
cough
diarrhea
loss
appetit
hemoptysi
fatigu
nasal
congest
runni
nose
chest
tight
sputum
hemoptysi
distinct
symptom
sever
patient
vs
p
short
breath
common
sever
patient
vs
p
incid
fever
symptom
sever
patient
nonsever
vs
p
clinic
symptom
nonsever
patient
underli
diseas
patient
hypertens
indic
except
lactic
acid
also
show
signific
differ
nonsever
sever
p
addit
valley
valu
lymphocyt
count
lower
peak
valu
bnp
ddimer
higher
sever
patient
nonsever
one
p
addit
found
proport
abnorm
lactic
dehydrogenas
total
protein
pondu
hydrogenii
glutam
oxalacet
transaminas
creatin
kinas
mb
creatin
kinas
urea
nitrogen
low
patient
abnorm
glutam
oxalacet
transaminas
lactic
dehydrogenas
creatin
kinas
mb
tend
occur
sever
patient
p
indic
signific
differ
concern
chang
cours
diseas
especi
predict
sever
diseas
lymphocyt
count
crp
ddimer
bnp
albumin
potassium
abnorm
throughout
cours
sever
patient
figur
suggest
abnorm
indic
earli
predict
progress
sever
diseas
lymphocyt
crp
recoveri
slow
sever
patient
figur
must
attent
balanc
earli
immun
respons
later
inflammatori
reaction
especi
first
week
cours
diseas
level
ddimer
bnp
gradual
increas
first
week
cours
diseas
reach
peak
day
cours
diseas
slowli
decreas
suggest
risk
secondari
thrombosi
myocardi
injuri
paid
attent
peak
period
recoveri
hypoalbuminemia
still
slow
case
continu
supplement
albumin
per
day
last
whole
cours
sever
patient
also
suggest
consumpt
loss
albumin
may
persist
hypokalemia
also
obviou
sever
patient
basic
maintain
normal
rang
activ
potassium
supplementationth
overal
cours
diseas
sever
patient
last
three
week
indic
return
normal
level
figur
shown
patient
classifi
mild
oi
sever
critic
oi
stage
among
sever
patient
three
patient
sever
admiss
patient
progress
rapidli
nonsever
sever
stage
case
develop
critic
stage
oxygen
index
decreas
less
compar
characterist
symptom
laboratori
result
group
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
differ
stage
addit
oxygen
index
import
indic
concern
predict
effect
chang
clinic
symptom
relev
laboratori
indic
also
select
analyz
signific
abnorm
chang
relev
symptom
laboratori
indic
three
stage
cours
hemoptysi
dyspnea
hyperbilirubinemia
high
high
ldh
common
sever
critic
stage
mild
stage
p
lymphocyt
count
crp
ddimer
bnp
albumin
gener
abnorm
cours
patient
abnorm
chang
signific
aggrav
diseas
p
deterior
indic
indic
patient
condit
rapid
progress
requir
close
monitor
earli
intervent
blood
rna
detect
patient
enrol
studi
result
viral
nucleic
acid
interpret
posit
result
four
patient
oxygen
index
patient
lower
suggest
patient
posit
blood
sarscov
nucleic
acid
test
high
potenti
risk
like
progress
sever
critic
diseas
chang
condit
close
observ
pneumonia
like
chang
import
lung
sign
chang
lung
ct
progress
sever
diseas
common
sign
lung
ct
groundglass
opac
ggo
highdens
linelik
flakelik
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
lesion
rang
lung
ct
scan
saw
greater
frequenc
bilater
lung
involv
greater
number
pulmonari
lobe
involv
higher
frequenc
consolid
mediastin
lymph
node
enlarg
sever
case
nonsever
one
vs
p
tabl
suggest
lung
involv
multipl
lobe
involv
rapid
lesion
progress
import
indic
predict
diseas
progress
sever
diseas
basi
respect
clinic
characterist
current
known
patholog
process
team
mainli
adopt
symptomat
support
treatment
measur
blind
medic
avoid
treatment
medicin
use
consid
effect
protect
support
patient
immun
function
virus
shown
tabl
due
common
hypoproteinemia
hypokalemia
provid
correspond
supplement
maintain
bodi
fluid
electrolyt
intern
environ
nutrit
balanc
especi
sever
patient
albumin
given
adjust
accord
heart
function
appropri
plasma
supplement
appli
sever
critic
case
could
suppli
immunoglobulin
lymphokin
support
bodi
normal
antivir
effect
think
plasma
especi
fresh
plasma
supplement
better
support
treatment
effect
extract
immunoglobulin
critic
ill
patient
appropri
dose
methylprednisolon
given
exert
antiinflammatori
effect
suppress
inflammatori
storm
caus
bodi
excess
immun
oxygen
therapi
given
patient
earli
stage
oi
declin
mediumhigh
flow
rate
inhal
oxygen
nasal
cathet
maintain
higher
oi
declin
continu
highflow
nasal
cannula
oxygen
therapi
hfnc
appli
earli
possibl
found
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
hfnc
could
achiev
good
blood
oxygen
mainten
effect
even
sever
critic
patient
better
toler
noninvas
mechan
ventil
earli
appreci
intervent
treatment
one
case
took
invas
mechan
ventil
short
time
studi
patient
treat
methylprednisolon
case
deal
high
fever
small
dose
case
rescu
theyhad
sudden
respiratori
distress
sharp
decreas
oi
patient
oi
close
applic
methylprednisolon
vari
time
singl
time
possibl
applic
recommend
rather
continu
longterm
applic
singl
dose
methylprednisolon
accord
sever
oxygen
index
speed
progress
product
inflammatori
factor
bodi
weight
age
underli
diseas
condit
shown
figur
treatment
methylprednisolon
patient
oi
improv
significantli
one
avoid
invas
mechan
ventil
import
applic
principl
methylprednisolon
shown
tabl
otherwis
import
prevent
possibl
side
effect
advanc
proton
pump
inhibitor
appropri
anticoagul
monitor
blood
pressur
blood
glucos
electrolyt
disord
patient
treat
methylprednisolon
gastrointestin
bleed
manifest
obviou
chang
blood
glucos
blood
pressur
osteonecrosi
femor
head
onfh
onemonthfollow
analyz
effect
methylprednisolon
time
negativeconvers
test
nasopharyng
swab
time
negativeconvers
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
test
patient
without
methylprednisolon
respect
statist
differ
two
group
p
figur
indic
applic
methylprednisolon
accord
principl
extend
clear
time
march
global
case
fatal
rate
cohort
studi
patient
wuhan
earli
stage
epidem
case
admit
intens
care
unit
icu
case
die
last
anoth
cohort
studi
patient
case
transfer
icu
case
die
fatal
rate
significantli
higher
sever
patient
treatment
mechan
ventil
critic
patient
bring
also
huge
medic
burden
far
specif
drug
found
success
therefor
extrem
import
recogn
predict
risk
factor
diseas
aggrav
identifi
sever
diseas
earli
give
scientif
effect
treatment
program
block
progress
sever
diseas
avoid
intub
invas
mechan
ventil
critic
diseas
reduc
case
fatal
rate
base
success
treatment
patient
includ
sever
critic
hospit
would
like
share
discuss
experi
recogn
intervent
sever
earli
time
consist
previou
research
persist
worsen
hypoxemia
low
lymphocyt
count
hypoalbuminemia
hypokalemia
high
crp
high
ddimer
high
bnp
import
indic
predict
risk
factor
diseas
aggrav
studi
hypoxemia
common
clinic
featur
throughout
cours
diseas
patient
case
even
someon
short
breath
admiss
declin
oi
sever
patient
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
significantli
nonsever
case
short
breath
shown
sever
patient
icu
patient
research
huang
et
al
larg
scale
multicent
research
patient
provinc
report
sever
case
low
lymphocyt
count
high
crp
high
ddimer
respect
signific
differ
nonsever
one
research
huang
low
lymphocyt
count
hypoalbuminemia
high
ddimer
found
common
sever
patient
particularli
critic
case
icu
addit
also
found
hypokalemia
high
bnp
signific
sever
case
nonsever
one
addit
viremia
also
paid
attent
predictor
progress
sever
except
abnorm
valu
indic
found
import
observ
chang
trend
indic
cours
diseas
signific
low
lymphocyt
count
high
crp
appear
sever
patient
begin
continu
whole
cours
indic
imbal
earli
immun
respons
later
inflammatori
reaction
liu
et
al
report
mean
day
ill
onset
icu
admiss
sever
critic
type
studi
peak
obviou
abnorm
ddimer
bnp
appear
day
diseas
cours
decreas
slowli
indic
earli
recognit
critic
sign
risk
secondari
thrombosi
myocardi
injuri
persist
hypoalbuminemia
hypokalemia
suggest
imbal
homeostasi
time
instruct
treatment
characterist
imag
find
ggo
nodul
stripe
patchi
consolid
bronchial
abnorm
consist
previou
studi
abnorm
imag
lung
ct
correspond
patholog
featur
pneumonia
two
type
acut
exud
patholog
chang
consid
correspond
imag
chang
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
accord
clinic
characterist
earli
time
intervent
import
studi
none
patient
basic
diseas
immun
dysfunct
therefor
consid
immun
dysfunct
intern
environment
disord
transient
viru
infect
treatment
mainli
focus
symptomat
support
treatment
earli
stage
adequ
supplement
albumin
plasma
potassium
order
maintain
stabil
intracellular
environ
adequ
reactiv
bodi
immun
clean
consist
lei
zhang
opinion
time
continu
applic
small
dose
glucocorticoid
avoid
case
suppress
bodi
immun
function
stage
hfnc
appli
earli
possibl
patient
progress
declin
oi
found
hfnc
could
achiev
good
blood
oxygen
mainten
effect
even
sever
critic
patient
better
toler
noninvas
mechan
ventil
common
indic
invas
mechan
ventil
strictli
control
critic
patient
base
experi
appropri
puls
methylprednisolon
applic
severecrit
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
patient
demand
improv
blood
oxygen
reduc
util
rate
invas
mechan
ventil
case
fatal
rate
medic
burden
significantli
metaanalysi
show
glucocorticoid
effect
drug
suppress
occurr
inflammatori
storm
safe
within
certain
dose
rang
emerg
inflammatori
storm
often
lifethreaten
short
time
varieti
inflammatori
factor
effect
singl
mab
evalu
inflammatori
storm
could
suppress
time
multipl
organ
failur
death
might
caus
far
glucocorticoid
may
uniqu
effect
medicin
suppress
progress
inflammatori
storm
appropri
reason
applic
applic
glucocorticoid
viral
pneumonia
current
controversi
retrospect
cohort
studi
sar
show
glucocorticoid
reduc
case
fatal
rate
hospit
stay
also
studi
show
glucocorticoid
may
increas
case
fatal
rate
sar
patient
delay
viru
clearanc
time
patient
middl
east
respiratori
syndrom
mer
influenza
viru
pneumonia
use
glucocorticoid
also
controversi
applic
indic
dosag
corticosteroid
strictli
control
begin
epidem
corticosteroid
recommend
use
treatment
lung
injuri
shock
outsid
clinic
trial
although
issu
alway
controversi
usag
corticosteroid
obvious
restrict
role
underestim
greatli
obviou
effect
methylprednisolon
therapi
studi
invas
mechan
ventil
avoid
patient
time
use
invas
mechan
ventil
shorten
significantli
one
patient
medic
expens
reduc
greatli
death
happen
obviou
advers
reaction
onemonth
follow
accord
report
find
mani
critic
patient
admit
icu
time
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
qualif
condit
invas
mechan
ventil
treatment
hospit
admit
patient
case
methylprednisolon
therapi
might
effect
choic
base
data
experi
team
recommend
improv
statu
glucocorticoid
treatment
sever
organ
multicent
largescal
retrospect
studi
possibl
prospect
studi
summar
success
treatment
patient
sever
case
team
found
accur
time
identif
clinic
featur
sever
risk
earli
appropri
intervent
could
block
diseas
progress
appropri
dose
methylprednisolon
effect
avoid
invas
mechan
ventil
reduc
case
fatal
rate
sever
critic
patient
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
time
review
lung
ct
show
better
prognosi
progress
diseas
figur
figur
abbrevi
sd
standard
deviat
iqr
interquartilerang
p
consid
statist
signific
p
valu
indic
differ
among
nonsever
sever
patient
critic
patient
p
b
valu
indic
differ
nonsever
sever
patient
p
c
valu
indic
differ
nonsever
critic
patient
p
valu
indic
differ
sever
critic
patient
lung
ct
featur
patient
lowest
oxygen
index
